Foresite Capital Management I, LLC insider trades: 10x Genomics (TXG) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Foresite Capital Management I, LLC reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 13, 2020 | TXG | ↓ Sell | 1,450,000 | $80.13 | $116.2M | Indirect | May 14, 2020 (1d) |
| Mar 17, 2020 | TXG | ↓ Sell | 750,000 | $59.00 | $44.3M | Indirect | Mar 19, 2020 (2d) |
| Sep 12, 2019 | TXG | ↑ Buy | 187,500 | $39.00 | $7.3M | Indirect | Sep 16, 2019 (4d) |
| Jun 24, 2013 | AMBI | ↑ Buy | 79,569 | $6.93 | $551K | Indirect | Oct 16, 2013 (114d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TXG insiders
Open-market trades in the last 12 months
About Foresite Capital Management I, LLC's insider trades
Foresite Capital Management I, LLC is a 10% owner of 10x Genomics (TXG). Since Jun 24, 2013, it has reported 2 open-market purchases worth $7.9M and 2 sales worth $160.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (7 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TXG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.